​

Precision BioSciences (DTIL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Precision BioSciences Revenue Highlights

Latest Revenue (Y)

$48.73M

Latest Revenue (Q)

$576.00K

Main Segment (Y)

Therapeutics Segment

Main Geography (Y)

Therapeutics Segment

Precision BioSciences Revenue by Period

Precision BioSciences Revenue by Year

DateRevenueChange
2023-12-31$48.73M94.15%
2022-12-31$25.10M-78.28%
2021-12-31$115.53M375.72%
2020-12-31$24.29M9.20%
2019-12-31$22.24M104.34%
2018-12-31$10.88M67.84%
2017-12-31$6.48M-

Precision BioSciences generated $48.73M in revenue during NA 2023, up 94.15% compared to the previous quarter, and up 447.73% compared to the same period a year ago.

Precision BioSciences Revenue by Quarter

DateRevenueChange
2024-09-30$576.00K-98.85%
2024-06-30$49.90M183.77%
2024-03-31$17.58M149.84%
2023-12-31$7.04M-46.36%
2023-09-30$13.12M-33.70%
2023-06-30$19.79M125.39%
2023-03-31$8.78M-17.15%
2022-12-31$10.60M43.94%
2022-09-30$7.36M92.75%
2022-06-30$3.82M15.16%
2022-03-31$3.32M-47.67%
2021-12-31$6.34M-73.63%
2021-09-30$24.04M-65.07%
2021-06-30$68.81M320.85%
2021-03-31$16.35M84.82%
2020-12-31$8.85M20.14%
2020-09-30$7.36M583.02%
2020-06-30$1.08M-84.60%
2020-03-31$7.00M7.30%
2019-12-31$6.52M34.06%
2019-09-30$4.87M-9.72%
2019-06-30$5.39M-1.34%
2019-03-31$5.46M10.57%
2018-12-31$4.94M94.41%
2018-09-30$2.54M35.59%
2018-06-30$1.87M22.64%
2018-03-31$1.53M-

Precision BioSciences generated $576.00K in revenue during Q3 2024, up -98.85% compared to the previous quarter, and up 2.91% compared to the same period a year ago.

Precision BioSciences Revenue Breakdown

Precision BioSciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21Dec 20Dec 19
Therapeutics Segment$111.72M$21.86M$20.63M
Food Segment$3.81M$2.42M$1.61M

Precision BioSciences's latest annual revenue breakdown by segment (product or service), as of Dec 21: Therapeutics Segment (96.71%), and Food Segment (3.29%).

Quarterly Revenue by Product

Product/ServiceDec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Therapeutics Segment$5.36M$22.80M$67.89M$15.68M$8.32M$7.05M$1.02M$5.47M$6.28M$4.72M$4.82M$4.82M
Food Segment$977.00K$1.24M$918.00K$670.00K$524.00K$315.00K$58.00K$1.52M$247.00K$146.00K$570.00K$643.00K

Precision BioSciences's latest quarterly revenue breakdown by segment (product or service), as of Dec 21: Therapeutics Segment (84.59%), and Food Segment (15.41%).

Precision BioSciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20Dec 19
Food Segment$3.81M$2.42M$1.61M
Therapeutics Segment$111.72M$21.86M$20.63M

Precision BioSciences's latest annual revenue breakdown by geography, as of Dec 21: Therapeutics Segment (96.71%), and Food Segment (3.29%).

Quarterly Revenue by Country

CountryDec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Food Segment$977.00K$1.24M$918.00K$670.00K$524.00K$315.00K$58.00K$1.52M$247.00K$146.00K$570.00K$643.00K
Therapeutics Segment$5.36M$22.80M$67.89M$15.68M$8.32M$7.05M$1.02M$5.47M$6.28M$4.72M$4.82M$4.82M

Precision BioSciences's latest quarterly revenue breakdown by geography, as of Dec 21: Therapeutics Segment (84.59%), and Food Segment (15.41%).

Precision BioSciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALECAlector$97.06M$15.08M
DTILPrecision BioSciences$48.73M$576.00K
HOOKHOOKIPA Pharma$20.13M-
RVMDRevolution Medicines$11.58M-
MREOMereo BioPharma Group$10.00M-
STOKStoke Therapeutics$8.78M$4.89M
CYTKCytokinetics$7.53M$463.00K
PLRXPliant Therapeutics$1.58M-
BDTXBlack Diamond Therapeutics--
XFORX4 Pharmaceuticals-$560.00K
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
DYNDyne Therapeutics--
PASGPassage Bio--
TERNTerns Pharmaceuticals--
ELDNEledon Pharmaceuticals--

DTIL Revenue FAQ

What is Precision BioSciences’s yearly revenue?

Precision BioSciences's yearly revenue for 2023 was $48.73M, representing an increase of 94.15% compared to 2022. The company's yearly revenue for 2022 was $25.1M, representing a decrease of -78.28% compared to 2021. DTIL's yearly revenue for 2021 was $115.53M, representing an increase of 375.72% compared to 2020.

What is Precision BioSciences’s quarterly revenue?

Precision BioSciences's quarterly revenue for Q3 2024 was $576K, a -98.85% decrease from the previous quarter (Q2 2024), and a -95.61% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $49.9M, a 183.77% increase from the previous quarter (Q1 2024), and a 152.15% increase year-over-year (Q2 2023). DTIL's quarterly revenue for Q1 2024 was $17.58M, a 149.84% increase from the previous quarter (Q4 2023), and a 100.27% increase year-over-year (Q1 2023).

What is Precision BioSciences’s revenue growth rate?

Precision BioSciences's revenue growth rate for the last 3 years (2021-2023) was -57.82%, and for the last 5 years (2019-2023) was 119.12%.

What are Precision BioSciences’s revenue streams?

Precision BioSciences's revenue streams in c 21 are Therapeutics Segment, and Food Segment. Therapeutics Segment generated $111.72M in revenue, accounting 96.71% of the company's total revenue, up 411.01% year-over-year. Food Segment generated $3.81M in revenue, accounting 3.29% of the company's total revenue, up 57.14% year-over-year.

What is Precision BioSciences’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Precision BioSciences was Therapeutics Segment. This segment made a revenue of $111.72M, representing 96.71% of the company's total revenue.